Leukemia and Lymphoma Program News and Updates

1 - 10 of 31

CHOP Researchers Win Science Center Award to Develop AML Treatment

CHOP Researchers Win Science Center Award to Develop AML Treatment

The $200,000 award will fund research to develop a novel therapeutic that ignites the immune system and could act as a stand-alone treatment, as well as boost the effectiveness of existing immunotherapies.

Read more

AML Immunotherapy Trial Opens

Published on in Oncology Update

CHOP has opened a phase 1 trial using CAR T for tough acute myeloid leukemia, hoping to replicate the therapy’s success for acute lymphoblastic leukemia.


Pages